Page last updated: 2024-08-17

prednisone and navitoclax

prednisone has been researched along with navitoclax in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zinzani, PL1
Ammatuna, E; de Jong, MRW; Langendonk, M; Nijland, M; Reitsma, B; van den Berg, A; van Meerten, T; Visser, L1

Reviews

1 review(s) available for prednisone and navitoclax

ArticleYear
Advances in management of follicular lymphoma.
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:10

    Topics: Aniline Compounds; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Autografts; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Discovery; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Follicular; Molecular Targeted Therapy; Neoplasm Staging; Prednisolone; Prednisone; Radioimmunotherapy; Rituximab; Sulfonamides; Vincristine

2014

Other Studies

1 other study(ies) available for prednisone and navitoclax

ArticleYear
Heterogeneous Pattern of Dependence on Anti-Apoptotic BCL-2 Family Proteins upon CHOP Treatment in Diffuse Large B-Cell Lymphoma.
    International journal of molecular sciences, 2019, Nov-30, Volume: 20, Issue:23

    Topics: Aniline Compounds; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bcl-2-Like Protein 11; bcl-X Protein; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Survival; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Large B-Cell, Diffuse; Myeloid Cell Leukemia Sequence 1 Protein; Prednisone; Prognosis; Proto-Oncogene Proteins c-bcl-2; Pyrimidines; Rituximab; Signal Transduction; Sulfonamides; Thiophenes; Treatment Outcome; Vincristine

2019